Repligen (RGEN) Tops Q2 EPS by 15c, Revenues Beat; Raises FY20 EPS/Revenue Guidance Above Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. MRK
7. LVS
8. SAP
9. CSX
10. LRCX

Go back to Repligen (RGEN) Tops Q2 EPS by 15c, Revenues Beat; Raises FY20 EPS/Revenue Guidance Above Consensus

Repligen Reports Second Quarter 2020 Financial Results and Updates Full Year 2020 Financial Guidance

July 30, 2020 7:30 AM EDT

Reports record quarterly revenue of $87.5 millionOverall revenue grew 24% year-over-year, with organic growth of 19% Raises revenue guidance to $332-$340 million for full year 2020, representing 18%-21% organic growthCompletes acquisition of silicone molding and tubing manufacturer Engineered Molding Technology

WALTHAM, Mass., July 30, 2020 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN), a life sciences company focused on bioprocessing technology leadership, today reported financial results for its second quarter of 2020. Provided in this press release are financial highlights for the three- and six- month periods... More